Start free trial
Markets India Stocks Health Technology Pharmaceuticals: Major

NATCO PHARMA LTD
NATCOPHARM BSE

NATCOPHARM
NATCO PHARMA LTD BSE
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Technicals Financials

NATCOPHARM Stock Chart

Ideas

Videos only
Natco Pharma Cmp 991 dated 21.5.2021
NATCOPHARM
, 1D
Long
NATCOPHARM: Natco Pharma Cmp 991 dated 21.5.2021

Natco Pharma Cmp 991 dated 21.5.2021 1. Inverted H&S on chart. 2. Volume break out, high volume. Buy for a tgt 1090 SL 925 It is just a view, pls trade at your own risk.

natco pharma- a long term investment bet
NATCOPHARM
, 1W
Long
NATCOPHARM: natco pharma- a long term investment bet

Fundamentally a strong company. shall be invested with a long term view. shall see 1050 in near term and might be a 2x candidate if held patiently for a couple of years. happy investing.

Natco Pharma
NATCOPHARM
, W
Long
NATCOPHARM: Natco Pharma

Fundamentals- 1)Excellent company with excellent fundamentals. 2)Expanding at very high rate. around 20% YoY basis. 3)Excellent numbers like operating profit, very good valuation with peers within the sector. 4)Awesome sales and profit figures. 5) Recently entered into the the medicines for Oncology 6)One of the very few pharmaceutical companies to manufacture...

NATCO PHARMA
NATCOPHARM
, W
NATCOPHARM: NATCO PHARMA

The information is for educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced by me. The information provided through my charts is for personal, non-commercial, educational use and display.

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

News